Asterion
Asterion: 3rd Generation Biopharmaceuticals | ProFuse | Third-generation AFT.
Launch date
Employees
Market cap
-
Enterprise valuation
$3—4m (Dealroom.co estimates May 2006.)
Company register number 04129500
Sheffield England (HQ)
Financials
Estimates*
GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
Profit | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
$680k | Seed | ||
Total Funding | $680k |
Recent News about Asterion
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.